StockNews.com Lowers BIOLASE (NASDAQ:BIOL) to Sell

StockNews.com downgraded shares of BIOLASE (NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a report published on Thursday morning. Separately, Benchmark lowered their price objective on shares of BIOLASE from $10.00 to $4.00 in a research report on Wednesday, September 20th. Check Out Our Latest Research Report on BIOLASE BIOLASE […]

Leave a Reply

Your email address will not be published.

Previous post Benchmark Reaffirms Buy Rating for Chefs’ Warehouse (NASDAQ:CHEF)
Next post StockNews.com Lowers Aspira Women’s Health (NASDAQ:AWH) to Sell